Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

The key role of ubiquitination and sumoylation in signaling and cancer: a research topic.

Wei W, Lin HK.

Front Oncol. 2012 Dec 5;2:187. doi: 10.3389/fonc.2012.00187. eCollection 2012. No abstract available.

3.

Low nuclear body formation and tax SUMOylation do not prevent NF-kappaB promoter activation.

Bonnet A, Randrianarison-Huetz V, Nzounza P, Nedelec M, Chazal M, Waast L, Pene S, Bazarbachi A, Mahieux R, Bénit L, Pique C.

Retrovirology. 2012 Sep 25;9:77. doi: 10.1186/1742-4690-9-77.

4.

Ubiquitination and sumoylation of the HTLV-2 Tax-2B protein regulate its NF-κB activity: a comparative study with the HTLV-1 Tax-1 protein.

Turci M, Lodewick J, Di Gennaro G, Rinaldi AS, Marin O, Diani E, Sampaio C, Bex F, Bertazzoni U, Romanelli MG.

Retrovirology. 2012 Dec 7;9:102. doi: 10.1186/1742-4690-9-102.

5.

Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate.

Fukuda I, Ito A, Hirai G, Nishimura S, Kawasaki H, Saitoh H, Kimura K, Sodeoka M, Yoshida M.

Chem Biol. 2009 Feb 27;16(2):133-40. doi: 10.1016/j.chembiol.2009.01.009.

6.

Wnt signaling in stem and cancer stem cells.

Holland JD, Klaus A, Garratt AN, Birchmeier W.

Curr Opin Cell Biol. 2013 Apr;25(2):254-64. doi: 10.1016/j.ceb.2013.01.004. Epub 2013 Jan 21. Review.

PMID:
23347562
7.

Ubiquitination of PCNA and its essential role in eukaryotic translesion synthesis.

Chen J, Bozza W, Zhuang Z.

Cell Biochem Biophys. 2011 Jun;60(1-2):47-60. doi: 10.1007/s12013-011-9187-3. Review.

PMID:
21461937
8.

Intrinsic disorder in ubiquitination substrates.

Hagai T, Azia A, Tóth-Petróczy Á, Levy Y.

J Mol Biol. 2011 Sep 23;412(3):319-24. doi: 10.1016/j.jmb.2011.07.024. Epub 2011 Jul 23.

PMID:
21802429
9.

SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone.

Chung V, Zhou B, Liu X, Zhu L, Boo LM, Nguyen HV, Ann DK, Song J, Chen Y, Yen Y.

Mol Cancer Ther. 2006 Mar;5(3):533-40.

10.

SUMOylation of DEC1 protein regulates its transcriptional activity and enhances its stability.

Hong Y, Xing X, Li S, Bi H, Yang C, Zhao F, Liu Y, Ao X, Chang AK, Wu H.

PLoS One. 2011;6(8):e23046. doi: 10.1371/journal.pone.0023046. Epub 2011 Aug 1.

11.

SUMOylation and cell signalling.

Andreou AM, Tavernarakis N.

Biotechnol J. 2009 Dec;4(12):1740-52. doi: 10.1002/biot.200900219. Review.

PMID:
19946876
12.

Ubiquitin-like protein modifications in prostate and breast cancer.

Wu F, Mo YY.

Front Biosci. 2007 Jan 1;12:700-11. Review.

PMID:
17127330
13.

MAP Kinase: SUMO pathway interactions.

Yang SH, Sharrocks AD.

Methods Mol Biol. 2010;661:343-67. doi: 10.1007/978-1-60761-795-2_21.

PMID:
20811994
14.

SnapShot: The SUMO system.

Creton S, Jentsch S.

Cell. 2010 Nov 24;143(5):848-848.e1. doi: 10.1016/j.cell.2010.11.026. No abstract available.

15.

SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation.

Ran Y, Liu TT, Zhou Q, Li S, Mao AP, Li Y, Liu LJ, Cheng JK, Shu HB.

J Mol Cell Biol. 2011 Oct;3(5):283-92. doi: 10.1093/jmcb/mjr020.

PMID:
22028379
16.

Sumoylation in neurodegenerative diseases.

Krumova P, Weishaupt JH.

Cell Mol Life Sci. 2013 Jun;70(12):2123-38. doi: 10.1007/s00018-012-1158-3. Epub 2012 Sep 25. Review.

PMID:
23007842
17.

Role of ubiquitination in IGF-1 receptor signaling and degradation.

Sehat B, Andersson S, Vasilcanu R, Girnita L, Larsson O.

PLoS One. 2007 Apr 4;2(4):e340.

18.

Ubiquitination and de-ubiquitination: role in regulation of signaling by Toll-like receptors.

Lowe EL, Doherty TM, Karahashi H, Arditi M.

J Endotoxin Res. 2006;12(6):337-45. Review.

PMID:
17254387
19.

Regulation of TNF-induced NF-κB activation by different cytoplasmic ubiquitination events.

Verhelst K, Carpentier I, Beyaert R.

Cytokine Growth Factor Rev. 2011 Oct-Dec;22(5-6):277-86. doi: 10.1016/j.cytogfr.2011.11.002. Epub 2011 Nov 25. Review.

PMID:
22119011
20.

HTLV-2B Tax oncoprotein is modified by ubiquitination and sumoylation and displays intracellular localization similar to its homologue HTLV-1 Tax.

Turci M, Lodewick J, Righi P, Polania A, Romanelli MG, Bex F, Bertazzoni U.

Virology. 2009 Mar 30;386(1):6-11. doi: 10.1016/j.virol.2009.01.003. Epub 2009 Feb 4.

Supplemental Content

Support Center